InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Cross Herb, 首席财务官. Director active across 1 company, notably Atreca, Inc.. Aggregated, 4 reports have been published. Split: 0 buy · 2 sells. Total volume traded: €18k. History available since 9 September 2021. The latest transaction was disclosed on 2 August 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Cross Herb
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
5,487 股@ US$0.952225.9% 占其流量Class A Common StockSEC:0001209191-23-044684:0
43,750 股0Class A Common StockSEC:0001209191-23-008957:0
7,646 股@ US$1.775274.1% 占其流量Class A Common StockSEC:0001209191-22-050777:0
42,200 股0Class A Common StockSEC:0001209191-21-055808:0
4 条申报中的 4 条
About Cross Herb
Herb Cross is the Chief Financial Officer of Atreca, Inc. In this role, he oversees all financial activities of the company, including budgeting, financial analysis, and investment management. His expertise in finance is essential to support Atreca's growth and profitability. Herb Cross also contributes to the company's overall strategy by providing accurate financial analyses and strategic advice.
